XML 71 R60.htm IDEA: XBRL DOCUMENT v3.8.0.1
Disposition (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended 12 Months Ended
Dec. 14, 2016
Mar. 31, 2018
Apr. 01, 2017
Mar. 31, 2018
Apr. 01, 2017
Sep. 30, 2017
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Proceeds from sale of business       $ 0.0 $ 1,865.0  
Gain on sale of business   $ 0.0 $ 899.7 0.0 899.7  
Blood Screening Business [Member]            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Gross proceeds on sale $ 1,850.0          
Proceeds from sale of business     1,865.0      
Gain on sale of business     899.7      
Tax obligation for Blood Screening           $ 649.5
Proceeds allocated to manufacture of inventory           $ 13.1
Disposal Group, Including Discontinued Operation, Revenue   $ 11.3 31.3 23.9 $ 96.5  
Disposal Group, Including Discontinued Operation, Operating Income (Loss)     $ 17.3 $ 45.8    
Blood Screening Business [Member] | Grifols [Member] | Minimum            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Disposal Group, Including Discontinued Operations, Period to Provide Transition Services After Disposal     2 years      
Blood Screening Business [Member] | Grifols [Member] | Maximum            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Disposal Group, Including Discontinued Operations, Period to Provide Transition Services After Disposal     3 years